EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
13.47
-0.13 (-0.96%)
At close: Apr 28, 2026, 4:00 PM EDT
13.45
-0.02 (-0.15%)
After-hours: Apr 28, 2026, 6:14 PM EDT

EyePoint Market Cap

EyePoint has a market cap or net worth of $1.12 billion as of April 28, 2026. Its market cap has increased by 240.66% in one year.

Market Cap
1.12B
Enterprise Value
840.54M
1-Year Change
240.66%
Ranking
Category
Stock Price
$13.47

Market Cap Chart

Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $1.12B, an increase of 189.20%. That is a compound annual growth rate of 5.12%.

History

DateMarket Cap% Change
Apr 27, 20261.13B-24.98%
Dec 31, 20251.51B197.44%
Dec 31, 2024508.50M-37.68%
Dec 29, 2023816.00M583.99%
Dec 30, 2022119.30M-66.13%
Dec 31, 2021352.20M273.09%
Dec 31, 202094.40M-43.68%
Dec 31, 2019167.60M-6.53%
Dec 31, 2018179.30M266.67%
Dec 29, 201748.90M-16.27%
Dec 30, 201658.40M-58.82%
Dec 31, 2015141.80M17.58%
Dec 31, 2014120.60M12.71%
Dec 31, 2013107.00M279.43%
Dec 31, 201228.20M22.08%
Dec 30, 201123.10M-75.61%
Dec 31, 201094.70M44.14%
Dec 31, 200965.70M281.98%
Dec 31, 200817.20M-70.19%
Dec 31, 200757.70M-25.93%
Dec 29, 200677.90M-62.73%
Dec 30, 2005209.00M-46.22%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
DBV Technologies 1.22B
GH Research 1.22B
MoonLake Immunotherapeutics 1.21B
Pharming Group 1.18B
UroGen Pharma 1.16B
uniQure 1.13B
Septerna 1.13B
Aktis Oncology 1.11B
Market Cap Rankings